Webb16 nov. 2009 · Protocol for the ProFHER (PROximal Fracture of the Humerus: Evaluation by Randomisation) trial: a pragmatic multi-centre randomised controlled trial of surgical versus non-surgical treatment for proximal fracture of the humerus in adults. Helen Handoll 1, Stephen Brealey 2, Amar Rangan 3, David Torgerson 2, Laura Dennis 1, Alison … WebbProFHER-2 is a lini- cal Trial for Patients aged 65 and over who have a confirmed three or four part fracture of the proxi- mal humerus (upper part of the arm at the shoulder). August 2024 Issue 1 Page 2 Updates Recruitment 1 participant has been recruited which is 0.3% of our total target of 380! There are 34 months left of recruitment.
ProFHER-2 page ECCH
WebbEffectiveness and cost-effectiveness of reverse shoulder arthroplasty versus hemiarthroplasty versus non-surgical care for acute 3 and 4 part fractures of the proximal humerus in patients aged over 65 years – the PROFHER-2 randomised trial. The PROFHER-2 trial is a multicentre, pragmatic randomised controlled trial that will evaluate whether ... Webb16 mars 2024 · March 16, 2024. 251. First there was the Priest. Then came the Prophet. Now the new RTI Prophet II has been launched at the 2024 IWA OutdoorClassics show in Nuremberg. Thanks to the company, HAM is able to bring you details of this new model from the Slovenian company. In fact, there’s actually two versions of the RTI Prophet II. chelsea salaries
Pro 2 - Sequential
WebbThe ProFHER (PROximal Fracture of the Humerus: Evaluation by Randomisation) trial – a pragmatic multicentre randomised controlled trial evaluating the clinical effectiveness and cost-effectiveness of surgical compared with non-surgical treatment for proximal fracture of the humerus in adults - NCBI Bookshelf Webb1 apr. 2008 · The Proximal Fracture of the Humerus: Evaluation by Randomisation (ProFHER) trial is a multicentre, pragmatic randomised controlled trial that aims to … WebbDiscussion The PROFHER-2 trial is designed to provide a robust answer to guide the treatment of patients aged 65 years or over who sustain 3- and 4-part proximal humeral fractures. flexpath index moderate 2025 fund